Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial

Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site revision label was updated to v3.5.5, replacing the previous v3.5.4, indicating a deployment update on the page. This update does not modify study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-05T08:21:35.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's versioning.
    Difference
    0.0%
    Check dated 2026-05-15T05:42:53.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page’s footer “Revision” value is updated from v3.5.2 to v3.5.3, indicating a site/version release rather than a change to the clinical trial record itself.
    Difference
    0.0%
    Check dated 2026-04-24T05:44:06.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:04:39.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision log updated to add v3.5.0 and remove v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T20:48:47.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now shown, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:13:23.000Z thumbnail image

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.